Account
Inquiry
Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist currently being developed for type 2 diabetes treatment. This innovative peptide demonstrates superior efficacy in glucose control and weight management compared to similar compounds.
The molecular structure of tirzepatide features a PEG-modified lysine side chain that enhances water solubility while maintaining biological activity. As a dual agonist, it shows greater affinity for GIP receptors than GLP-1 receptors, producing more significant reductions in hyperglycemia.
Clinical studies have demonstrated tirzepatide's potential for weight management, with trial participants showing average weight reductions of 15-20.9% depending on dosage. The peptide has received FDA Fast Track designation for obesity treatment applications.
Our pharmaceutical-grade tirzepatide is supplied as a white powder with 99.9% purity, packaged in convenient 10mg vials for research use. The compound has shown promising results in clinical trials for both diabetes management and weight loss applications.
For researchers looking to get tirzepatide online, we offer bulk quantities with customizable packaging options. Our production facility maintains strict quality control standards to ensure consistent peptide purity and performance.
When stored properly in cool, dry conditions away from light, tirzepatide maintains excellent stability. Researchers should aliquot the peptide according to experimental requirements and avoid repeated freeze-thaw cycles.
Note: This product is intended for research purposes only. Not for human consumption or diagnostic use. Proper safety protocols should be followed when handling all research compounds.
